Search research articles
Contact Us
Filters
Showing results (181-190 of 361) with videos related to
Page
of 37
Sort By:
Journal of the American College of Cardiology
|
January 28, 2022
Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure
Alvin Chandra, Hicham Skali, Brian Claggett, et al.
JACC. Heart Failure
|
April 1, 2017
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial
Inder S Anand, Brian Claggett, Jiankang Liu, et al.
Circulation. Heart Failure
|
April 13, 2018
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)
Orly Vardeny, Brian Claggett, Jessica Kachadourian, et al.
JACC. Heart Failure
|
September 13, 2020
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis
Luis E Rohde, Neal A Chatterjee, Muthiah Vaduganathan, et al.
European Journal of Heart Failure
|
October 18, 2018
Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy
Maja Cikes, Sergio Sanchez-Martinez, Brian Claggett, et al.
European Journal of Heart Failure
|
June 27, 2023
Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis
Daniel Modin, Mats Christian Højbjerg Lassen, Brian Claggett, et al.
Journal of the American Heart Association
|
August 24, 2022
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
Jenine E John, Brian Claggett, Hicham Skali, et al.
European Heart Journal
|
September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
European Journal of Heart Failure
|
February 13, 2018
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Lars H Lund, Brian Claggett, Jiankang Liu, et al.
American Heart Journal
|
August 25, 2015
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus
Eldrin F Lewis, Brian Claggett, Patrick S Parfrey, et al.
Page
of 37
Search research articles
Search
Showing results (181-190 of 361) with videos related to
Sort By:
Page
of 37
Journal of the American College of Cardiology
|
January 28, 2022
Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure
Alvin Chandra, Hicham Skali, Brian Claggett, et al.
JACC. Heart Failure
|
April 1, 2017
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial
Inder S Anand, Brian Claggett, Jiankang Liu, et al.
Circulation. Heart Failure
|
April 13, 2018
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)
Orly Vardeny, Brian Claggett, Jessica Kachadourian, et al.
JACC. Heart Failure
|
September 13, 2020
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis
Luis E Rohde, Neal A Chatterjee, Muthiah Vaduganathan, et al.
European Journal of Heart Failure
|
October 18, 2018
Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy
Maja Cikes, Sergio Sanchez-Martinez, Brian Claggett, et al.
European Journal of Heart Failure
|
June 27, 2023
Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis
Daniel Modin, Mats Christian Højbjerg Lassen, Brian Claggett, et al.
Journal of the American Heart Association
|
August 24, 2022
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
Jenine E John, Brian Claggett, Hicham Skali, et al.
European Heart Journal
|
September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
European Journal of Heart Failure
|
February 13, 2018
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Lars H Lund, Brian Claggett, Jiankang Liu, et al.
American Heart Journal
|
August 25, 2015
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus
Eldrin F Lewis, Brian Claggett, Patrick S Parfrey, et al.
Page
of 37